Cost avoidance analysis of outpatient parenteral antimicrobial therapy (OPAT) plan reconciliation for patients enrolled in value-based payment models at an academic hospital
Year: 2026
Type: article
Abstract: We previously characterized a reduction in unscheduled care following implementation of ID pharmacist review of outpatient parenteral antimicrobial therapy plans for patients discharging from acute care. In this report we demonstrate the cost avoidance that this intervention would be expected to generate for patients enrolled in value-based-care plans.
Language: English
Subfield: Applied Microbiology and Biotechnology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,719
Funder: National Institutes of Health
OpenAlex ID: W7147073264